Brief: Emmaus Life Sciences Announces Withdrawal Of Marketing Authorization Application To European Medicines Agency
19/09/2019 21:09
Sept 19 (Reuters) - Emmaus Life Sciences Inc EMMA.PK :
* EMMAUS LIFE SCIENCES ANNOUNCES WITHDRAWAL OF MARKETING
AUTHORIZATION APPLICATION TO EUROPEAN MEDICINES AGENCY
* EMMAUS LIFE SCIENCES INC - WITHDRAWAL OF MAA TO EUROPEAN
MEDICINES AGENCY FOR XYNDARI FOR TREATMENT OF SICKLE CELL
DISEASE
Source text for Eikon: ID:nPnblwsqta
Further company coverage: EMMA.PK
((Briefs@thomsonreuters.com;))
Recent news on Emmaus Life Sciences
See all newsEmmaus Life Sciences Q2 revenue soars on licensing deal
Emmaus Life Sciences Q1 revenue falls driven by lower sales in U.S.
Brief: Emmaus Life Sciences Enters License And Distribution Agreement With Neoimmunetech
Emmaus Life Sciences Q3 revenue falls 38%, swings to loss
Brief: Emmaus Life Sciences CFO Yasushi Nagasaki Resigns